Monoclonal Gammopathy of Undetermined Significance: all 102 studies
Page 1 of 2. Open to participants first (28), then studies with results posted, then the rest; newest registration first within each.
- Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine ImagingNot yet recruitingNCT07624760Not applicable
- FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor DiseaseRecruitingNCT07446777Not applicable
- Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGUS/SMM: A Pilot StudyNot yet recruitingNCT07305662Not applicable
- Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical EvolutionRecruitingNCT07214324
- Rifaximin Versus No Intervention for the Treatment of IgG/IgA (Non-IgM) Monoclonal Gammopathy of Undetermined SignificanceRecruitingNCT07209371Phase 2
- A Study of Carbon 13-based Deep Labelling of Bone Marrow CellsEnrolling by invitationNCT07057583
- Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant BiomarkersNot yet recruitingNCT06987708Not applicable
- Whole Body MRI in OncologyRecruitingNCT06895291
- Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal GammopathyRecruitingNCT06690593
- CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot StudyRecruitingNCT06644625
- Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUSRecruitingNCT06559033
- Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.Not yet recruitingNCT06489613
- MGUS/MM Awareness and Genetics Insights Campaign (MAGIC) Screening StudyEnrolling by invitationNCT06472830
- Promoting Diagnosis and Management of AL in Italy (ProDigALIty)RecruitingNCT06383143
- A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple MyelomaRecruitingNCT06140524Phase 2
- A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)RecruitingNCT06055894Not applicable
- Clonal Hematopoiesis of Immunological SignificanceNot yet recruitingNCT05969821
- The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE StudyRecruitingNCT05965115
- A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)RecruitingNCT05640843Not applicable
- Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor ConditionsRecruitingNCT05361694
- A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFHRecruitingNCT05283993
- Quality of Life in Patients With Asymptomatic Monoclonal GammopathiesRecruitingNCT05136807
- Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory HemopathiesNot yet recruitingNCT04702932
- Sleep Apnea in Patients With MGUS and MMRecruitingNCT04114084
- The Indiana Myeloma RegistryRecruitingNCT03616483
- Observational Prospective Research Study In Monoclonal Gammopathies leadINg to MyelomaRecruitingNCT02726750
- Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical OutcomeRecruitingNCT02269592
- Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample ResourceRecruitingNCT01408225
- A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)Active, not recruitingNCT04920084Not applicableResults posted
- Investigation of Metformin for the Prevention of Progression of Precursor Multiple MyelomaActive, not recruitingNCT04850846Phase 2Results posted
- Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate CancerCompletedNCT04731844Phase 2Results posted
- The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone LossCompletedNCT03951220Results posted
- Imaging in MGUS, SMM and MMCompletedNCT01237054Phase 2Results posted
- A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple MyelomaCompletedNCT01063907Phase 1/2Results posted
- Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple MyelomaTerminatedNCT00942422Phase 2Results posted
- Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)TerminatedNCT00899353Phase 2Results posted
- Methadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerTerminatedNCT00726830Not applicableResults posted
- American Ginseng in Treating Patients With Fatigue Caused by CancerCompletedNCT00719563Phase 3Results posted
- Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer PainCompletedNCT00666211Phase 3Results posted
- Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined SignificanceTerminatedNCT00665652Phase 2Results posted
- Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With CancerCompletedNCT00661999Phase 3Results posted
- Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined SignificanceTerminatedNCT00588822Phase 2Results posted
- Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainCompletedNCT00538850Phase 3Results posted
- Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by ChemotherapyCompletedNCT00416624Phase 2Results posted
- Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00245037Phase 1/2Results posted
- Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering MyelomaCompletedNCT00099047Phase 2Results posted
- Daratumumab for Polyneuropathy Associated With MGUSWithdrawnNCT06046287Phase 2
- Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related PolyneuropathyActive, not recruitingNCT05939037Phase 2
- Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation ProgramActive, not recruitingNCT05831358Not applicable
- Isatuximab in Type I CryoglobulinemiaStatus unknownNCT05114109Phase 2
- MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) SurveyStatus unknownNCT04727294
- Screening to Improve Survival in AL AmyloidosisCompletedNCT04615572
- Ibrutinib for the Treatment of COVID-19 in Patients Requiring HospitalizationCompletedNCT04439006Phase 1
- Observation of the Incidence and Natural History of MGUS in Patients Undergoing Weight Reduction SurgeryCompletedNCT03855878
- Iceland Screens, Treats or Prevents Multiple MyelomaActive, not recruitingNCT03327597Not applicable
- Dysregulation of Glutamine Activity in the Pathogenesis of Multiple MyelomaCompletedNCT03119883Not applicable
- Unravel MGUS (Monoclonal Gammopathy of Unknown Significance)Status unknownNCT02933021
- B-Cell Hematologic Malignancy Vaccination RegistryWithdrawnNCT02298816
- Comprehensive Frailty AssessmentCompletedNCT02033928
- Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple MyelomaCompletedNCT01955395Not applicable
- Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell TransplantCompletedNCT01588015Phase 1
- Imaging Studies and the Development of Multiple MyelomaWithdrawnNCT01571726Phase 2
- A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple MyelomaCompletedNCT01219010Phase 1
- Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)TerminatedNCT01109407
- Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM.TerminatedNCT01079429
- S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.CompletedNCT00919139
- S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or PlasmacytomaCompletedNCT00900263
- Studying Fentanyl in Patients With CancerTerminatedNCT00899951
- Proteases in Patients With Prostate Cancer That Has Spread to the BoneCompletedNCT00899665
- S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood DiseaseCompletedNCT00898066
- Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell TransplantCompletedNCT00445952
- Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal MetastasesCompletedNCT00424242Early Phase 1
- Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseNo longer availableNCT00423826
- Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other DiseasesCompletedNCT00376922Not applicable
- Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for CancerCompletedNCT00255749Phase 2
- 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic MastocytosisCompletedNCT00132015Phase 2
- Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell TransplantCompletedNCT00110045Phase 2
- Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for CancerCompletedNCT00070382Phase 3
- Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With CancerTerminatedNCT00062231Not applicable
- Pyroxamide in Treating Patients With Advanced CancerCompletedNCT00042900Phase 1
- Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionCompletedNCT00025415Phase 1
- Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer TreatmentCompletedNCT00008359Phase 3
- Beta Alethine in Treating Patients With MyelomaStatus unknownNCT00006466Phase 1/2
- Non-Ablative Allo HSCT For Hematologic Malignancies or SAACompletedNCT00006379Phase 2
- PS-341 in Treating Patients With Advanced CancerCompletedNCT00006362Phase 1
- Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer TreatmentCompletedNCT00006348Phase 3
- Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a CatheterCompletedNCT00006083Phase 3
- St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for CancerCompletedNCT00005805Phase 3
- Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00005804Phase 2
- Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00004904Phase 1
- EMD 121974 in Treating Patients With Locally Advanced or Metastatic CancerCompletedNCT00004258Phase 1
- Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00004232Phase 1
- 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow DisorderTerminatedNCT00004058Phase 1
- Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced CancerStatus unknownNCT00004036Phase 1
- Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer PatientsCompletedNCT00003938Phase 3
- Treatment for Chronic Pain in Patients With Advanced CancerCompletedNCT00003687Phase 3
- Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerCompletedNCT00003451Phase 1
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerCompletedNCT00003406Phase 1/2
- Combination Chemotherapy in Treating Patients With Advanced CancerCompletedNCT00003331Phase 1
- Monoclonal Antibody Therapy in Treating Patients With Advanced CancerCompletedNCT00003082Phase 1
← Monoclonal Gammopathy of Undetermined Significance overview